| mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.0092 |
0.9 |
| mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
| mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.9 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
0.005 |
0.9 |